Type 1 diabetes treatment and metabolic health survey
Part of Hormones & metabolism clinical trials.
This study looks at how people with type 1 diabetes are currently treated and their overall metabolic health (like blood sugar control). By participating, you'll help doctors understand what treatments work best and identify areas for improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes
- You meet at least one of these: had diabetic ketoacidosis (a serious high-sugar emergency) or ketones in urine at first diagnosis, have positive islet antibodies (proteins that attack insulin-making cells), or have low C-peptide levels (a sign your body makes little or no insulin)
- You are willing to use a continuous glucose monitor (a small device that tracks your blood sugar) and complete questionnaires
- Your diabetes is not another type (like type 2)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study looks at whether using a continuous glucose monitor (a small sensor that checks blood sugar levels around the clock) can help people who were just diagnosed with type 2 diabetes manage their blood sugar better. If you join, you would wear the sensor for a while and get regular feedback, which might help you learn how food and habits affect your sugar levels.
Hear when a new Type1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.